Ocugen, Inc. (OCGN)
1.225
-0.04
(-2.78%)
USD |
NASDAQ |
Jun 09, 16:00
1.225
0.00 (0.00%)
After-Hours: 20:00
Ocugen SG&A Expense (Quarterly) : 8.117M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| REGENXBIO, Inc. | 21.31M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| CytomX Therapeutics, Inc. | 10.69M |
| Krystal Biotech, Inc. | 41.01M |
| MeiraGTx Holdings Plc | 8.928M |